The Transplant immunosuppressive drugs market is projected to grow at a CAGR of 3.13% to reach a market size of US$185.901 billion by 2024, from US$154.513 billion in 2018. Transplants are also known as grafts or organ transplants where a section of a tissue or a complete organ from its original site is transferred to the area of interest in an individual (same or separate). Thus, the transplanted organ or graft continue to receive nourishment from the new and healthy environment. Immunosuppressive drugs are required for a patient to continue throughout his/her life post-transplant, referred to as maintenance drugs. In addition, induction drugs are given to patients immediately after the transplantation procedure is completed, this is for the prevention of early post-operative immune suppression. These drugs protect the body against rejection of the transplanted foreign organ or tissue by the body. The prevalence of chronic diseases is one of the major factors driving the growth of the immunosuppressive drugs market in the forecast period with the growing number of transplants.
Incidences of transplant rejection are further driving the market growth during the forecast period. However, the shortage of organ donors may impede the growth of the transplant immunosuppressive drugs market in the forecast period. Additionally, technological advancements in the transplant industry may provide an opportunity for market growth in the upcoming years.
The “Transplant Immunosuppressive Drugs Market – Forecasts from 2019 to 2024” is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, and geography.
The Transplant immunosuppressive drugs market on segmented based on type, application, and geography. Based on type the market has been segmented into Induction drugs and Maintenance drugs. By application, the market has been classified into Tissue transplantation and Organ transplantation.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024, taking 2018 as the base year. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and the Asia Pacific regions. The report also analyzes 15 major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the transplant immunosuppressive drugs market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the transplant immunosuppressive drugs market.
Segmentation
The Transplant immunosuppressive drugs market has been analyzed through following segments:
By Type
Induction Drugs
Maintenance Drugs
By Application
Tissue Transplantation
Organ Transplantation
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Others
.jpg)
